Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Symjepi
Symjepi
Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Fierce Pharma
Wed, 07/10/19 - 11:34 am
Novartis
Mylan
Pfizer
EpiPens
Sandoz
Symjepi
drug launches
Adamis Pharmaceuticals
Rival accuses Kaleo of cybersquatting in 'elaborate scheme'
Biopharma Dive
Wed, 07/3/19 - 12:02 am
Kaleo
Auvi-Q
Adamis Pharmaceuticals
Symjepi
cybersquatting
Sandoz launches EpiPen rival at $250 per two-pack
BioPharma Dive
Fri, 01/18/19 - 09:21 pm
Sandoz
Novartis
EpiPens
Symjepi
Adamis stock surges on release of EpiPen alternative
Marketwatch
Thu, 01/17/19 - 09:34 am
Adamis
Mylan
Sandoz
EpiPens
Symjepi
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Thu, 12/6/18 - 01:37 pm
Novartis
Sandoz
generics
Symjepi
EpiPens
Teva Pharmaceutical
Mylan
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
Novartis steps in to compete with Mylan’s Epipen
Drug Delivery Business News
Mon, 07/2/18 - 09:27 am
Adamis Pharmaceuticals
Novartis
Sandoz
Symjepi
Mylan
EpiPens
EpiPen alternative Symjepi gets FDA OK
BioPharma Dive
Fri, 06/16/17 - 09:46 pm
EpiPens
Mylan Labs
Symjepi
Adamis Pharmaceuticals
FDA